| scholarly article | Q13442814 |
| P50 | author | Didier Pittet | Q5274187 |
| Stephan Harbarth | Q63391550 | ||
| P2093 | author name string | J Pugin | |
| B Ricou | |||
| G E Grau | |||
| L Vadas | |||
| Geneva Sepsis Network | |||
| C Froidevaux | |||
| K Holeckova | |||
| P2860 | cites work | Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine | Q22306067 |
| The meaning and use of the area under a receiver operating characteristic (ROC) curve | Q29547182 | ||
| C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 | ||
| Diagnostic tests: distinguishing good tests from bad and even ugly ones | Q30305597 | ||
| Empirical evidence of design-related bias in studies of diagnostic tests | Q30776370 | ||
| The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis | Q32125356 | ||
| Rapid diagnostic methods in the detection of sepsis | Q33642578 | ||
| The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study | Q34314569 | ||
| Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis | Q35358768 | ||
| Predicting bacteremia in hospitalized patients. A prospectively validated model | Q39270698 | ||
| Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections | Q40631166 | ||
| Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables | Q40633286 | ||
| Procalcitonin concentrations in patients with neutropenic fever | Q40636900 | ||
| Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options | Q40785303 | ||
| Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis | Q41020817 | ||
| Procalcitonin--a new indicator of the systemic response to severe infections | Q41679971 | ||
| Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count | Q43102051 | ||
| Postoperative plasma concentrations of procalcitonin after different types of surgery | Q43567602 | ||
| Lack of specificity of procalcitonin for sepsis diagnosis in premature infants | Q44571851 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| sepsis | Q183134 | ||
| interleukins | Q194908 | ||
| diagnosis | Q16644043 | ||
| P304 | page(s) | 396-402 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis | |
| P478 | volume | 164 |
| Q35094247 | 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. |
| Q24806297 | 8th Annual Toronto Critical Care Medicine Symposium, 30 October-1 November 2003, Toronto, Ontario, Canada |
| Q91908687 | A current appraisal of evidence for the approach to sepsis and septic shock |
| Q35279631 | A study on biomarkers, cytokines, and growth factors in children with burn injuries. |
| Q36743345 | Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. |
| Q34181010 | Acute respiratory distress syndrome after bacteremic sepsis does not increase mortality |
| Q55256161 | Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock. |
| Q38005908 | An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients |
| Q44496351 | An extended leukocyte differential count (16 types of circulating leukocytes) using the CytoDiff flow cytometric system can provide information for the discrimination of sepsis severity and prediction of outcome in sepsis patients |
| Q36787187 | Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study |
| Q40880244 | Are prognostic scores and biomarkers such as procalcitonin the appropriate prognostic precursors for elderly patients with sepsis in the emergency department? |
| Q35494130 | Assessment of procalcitonin to predict outcome in hypothermia-treated patients after cardiac arrest |
| Q37630684 | Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study |
| Q64074825 | Association between serum levels of interleukin-6 on ICU admission and subsequent outcomes in critically ill patients with acute kidney injury |
| Q33753374 | B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients |
| Q37209299 | Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial |
| Q90270073 | Biomarkers for Point-of-Care Diagnosis of Sepsis |
| Q26785255 | Biomarkers for Sepsis: What Is and What Might Be? |
| Q38263097 | Biomarkers for community-acquired pneumonia in the emergency department |
| Q37496755 | Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis |
| Q37688126 | Biomarkers for sepsis: a review with special attention to India |
| Q37997820 | Biomarkers in community-acquired pneumonia |
| Q35604874 | Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study |
| Q42220979 | Biomarkers of sepsis. |
| Q78428734 | Biomarkers of sepsis: is procalcitonin ready for prime time? |
| Q52859823 | Calcitonin Precursors: Early Markers of Gut Barrier Dysfunction in Patients With Acute Pancreatitis |
| Q44415054 | Calcitonin gene related peptide and N-procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils |
| Q88951303 | Can Procalcitonin Be Used as a Reliable Marker for Infectious Fever in Patients with Intracranial Hemorrhage? |
| Q42269692 | Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study |
| Q64067143 | Changes in the levels of inflammatory markers after transthoracic device closure of ventricular septal defects in pediatric patients |
| Q26772133 | Circulating MicroRNAs as Biomarkers for Sepsis |
| Q36955225 | Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays |
| Q89357259 | Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study |
| Q91895896 | Circulating lncRNA ITSN1-2 is upregulated, and its high expression correlates with increased disease severity, elevated inflammation, and poor survival in sepsis patients |
| Q35036096 | Clinical evaluation of multiple inflammation biomarkers for diagnosis and prognosis for patients with systemic inflammatory response syndrome |
| Q21194921 | Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia |
| Q42207158 | Collagen-related biomarkers in severe sepsis: a big stretch? |
| Q36827369 | Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis |
| Q48987065 | Comparison of Fcγ receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients |
| Q99631926 | Comparison of Postoperative Changes in Inflammatory Marker Levels Between Transthoracic and Transcatheter Device Closures of Atrial Septal Defects in Children |
| Q59794696 | Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems |
| Q53833044 | Correlation of Procalcitonin and C-Reactive Protein with Intra-Abdominal Hypertension in Intra-Abdominal Infections: Their Predictive Role in the Progress of the Disease. |
| Q34999108 | Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients |
| Q40281751 | Coupled Plasma Filtration Adsorption (CPFA) plus Continuous Veno-Venous Haemofiltration (CVVH) versus CVVH alone as an adjunctive therapy in the treatment of sepsis |
| Q37347840 | Coupled Plasma Filtration and Adsorption (CPFA): A Single Center Experience |
| Q34550121 | Critical care medicine in AJRCCM 2001. |
| Q41881166 | Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia |
| Q35746578 | Delta Neutrophil Index as a Marker for Differential Diagnosis between Acute Graft Pyelonephritis and Acute Graft Rejection |
| Q36315278 | Delta neutrophil index is an independent predictor of mortality in septic acute kidney injury patients treated with continuous renal replacement therapy |
| Q57163111 | Design and rationale of the "Sedation strategy and cognitive outcome after critical illness in early childhood" study |
| Q61757070 | Diagnose und Therapie der Sepsis |
| Q61757043 | Diagnose und kausale Therapie der Sepsis |
| Q44754456 | Diagnosis and therapy of sepsis |
| Q36438852 | Diagnosis and treatment of severe sepsis |
| Q34001903 | Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients |
| Q33276665 | Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia |
| Q37852470 | Diagnostic and prognostic biomarkers of sepsis in critical care |
| Q34240021 | Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment |
| Q64103776 | Diagnostic effectiveness of soluble triggering receptor expressed on myeloid cells-1 in sepsis, severe sepsis and septic shock |
| Q36553526 | Diagnostic markers of sepsis in the emergency department |
| Q88926711 | Diagnostic value of procalcitonin and CRP in critically ill patients admitted with suspected sepsis |
| Q51105094 | Diagnostic value of sTREM-1 and procalcitonin levels in the early diagnosis of sepsis. |
| Q35960339 | Diffuse postoperative peritonitis -- value of diagnostic parameters and impact of early indication for relaparotomy |
| Q40443837 | Does serum procalcitonin aid in the diagnosis of bloodstream infection regardless of whether patients exhibit the systemic inflammatory response syndrome? |
| Q26828493 | Duration of antimicrobial therapy in community acquired pneumonia: less is more |
| Q55361514 | Early IL-6 response in sepsis is correlated with mortality and severity score. |
| Q36295952 | Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity |
| Q47739222 | Effect of Continuous Digital Hypothermia on Lamellar Inflammatory Signaling When Applied at a Clinically-Relevant Timepoint in the Oligofructose Laminitis Model. |
| Q48544581 | Effect of introducing procalcitonin on antimicrobial therapy duration in patients with sepsis and/or pneumonia in the intensive care unit |
| Q34301553 | Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. |
| Q39944566 | Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. |
| Q97646219 | Elevated Interleukin-6 Levels within 72 Hours Post Admission Are Associated with Disease Progression in Nonseptic Critically Ill Children |
| Q35857871 | Elevated Serum PCT in Septic Shock With Endotoxemia Is Associated With a Higher Mortality Rate |
| Q44506811 | Endotoxin-induced cardiovascular dysfunction in mice: effect of simvastatin |
| Q36749144 | Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. |
| Q51022580 | Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities. |
| Q44538842 | Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis |
| Q80079911 | Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock |
| Q28293840 | Expression of triggering receptor on myeloid cell 1 and histocompatibility complex molecules in sepsis and major abdominal surgery |
| Q36204941 | Extended leukocyte differential count and C-reactive protein in septic patients with liver impairment: diagnostic approach to evaluate sepsis in intensive care unit |
| Q47102780 | Fever after bronchoscopy: serum procalcitonin enables early diagnosis of post-interventional bacterial infection. |
| Q34628768 | Forty years of calcitonin--where are we now? A tribute to the work of Iain Macintyre, FRS. |
| Q52909875 | Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. |
| Q33403981 | Immature platelet fraction in predicting sepsis in critically ill patients |
| Q36419666 | Immature platelet fraction in septic patients: clinical relevance of immature platelet fraction is limited to the sensitive and accurate discrimination of septic patients from non-septic patients, not to the discrimination of sepsis severity |
| Q37987042 | Immune regulation of procalcitonin: a biomarker and mediator of infection |
| Q112290940 | Immunometabolic signatures predict risk of progression to sepsis in COVID-19 |
| Q21195133 | Impact of interleukin-10, soluble CD25 and interferon-γ on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study |
| Q33389518 | Impact of previous sepsis on the accuracy of procalcitonin for the early diagnosis of blood stream infection in critically ill patients |
| Q37993724 | Impact of the use of procalcitonin assay in hospitalized adult patients with pneumonia at a community acute care hospital |
| Q30313842 | Impairment of oxygenation of patients in surgical intensive care : Early symptom of severe sepsis |
| Q36099375 | Improved diagnostic approaches to infection/sepsis detection |
| Q37356063 | Increased serum procalcitonin levels in pregnant patients with asymptomatic bacteriuria |
| Q36026253 | Inflammasome-regulated cytokines are critical mediators of acute lung injury |
| Q37270551 | Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ. |
| Q73288892 | Influence of Systemic Inflammatory Response Syndrome and Sepsis on Outcome of Critically Ill Infected Patients |
| Q41340132 | Interleukin-6 as a prognostic marker in dogs in an intensive care unit |
| Q24186689 | Interleukin-6 for diagnosis of sepsis in critically ill adult patients |
| Q37861389 | Interleukin-6 in surgery, trauma, and critical care part II: clinical implications. |
| Q33691672 | Invasive pulmonary aspergillosis in a patient presenting with idiopathic systemic capillary leak syndrome |
| Q64242955 | Is Interleukin-6 a better predictor of successful antibiotic therapy than procalcitonin and C-reactive protein? A single center study in critically ill adults |
| Q38263160 | Is serum procalcitonin measurement a useful addition to a rheumatologist's repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections |
| Q36931182 | Is there value in plasma cytokine measurements in patients with severe trauma and sepsis? |
| Q34013704 | Lipopolysaccharide-binding protein for monitoring of postoperative sepsis: complemental to C-reactive protein or redundant? |
| Q46804479 | Liver function tests in patients with bacteremia |
| Q45122666 | Main determinants of liver microcirculation during systemic inflammation |
| Q24813253 | Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection |
| Q39139022 | Mass spectrometry for the discovery of biomarkers of sepsis |
| Q42930048 | Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis? |
| Q24802598 | Measurements in the intensive care unit: what do they mean? |
| Q61757056 | Meta-analysis of procalcitonin for sepsis detection |
| Q53025139 | Meta-analysis of procalcitonin for sepsis detection. |
| Q38045406 | Metabolic and toxicological considerations for sepsis drug treatments. |
| Q38726759 | MiR-212-3p inhibits LPS-induced inflammatory response through targeting HMGB1 in murine macrophages |
| Q29994808 | Microfluidic system for monitoring temporal variations of hemorheological properties and platelet adhesion in LPS-injected rats |
| Q35559416 | Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study |
| Q40030842 | Multiplex cytokine analyses in dogs with pyometra suggest involvement of KC-like chemokine in canine bacterial sepsis |
| Q99408933 | Multisystem inflammatory syndrome in children: A systematic review |
| Q34303687 | New approaches to sepsis: molecular diagnostics and biomarkers. |
| Q47103723 | Non-coding RNA: a potential biomarker and therapeutic target for sepsis |
| Q64903655 | P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis. |
| Q40347415 | Pancreatic stone protein and soluble CD25 for infection and sepsis in an emergency department |
| Q36633810 | Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management |
| Q64070177 | Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial |
| Q36765740 | Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis |
| Q36667012 | Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia |
| Q57217849 | Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery |
| Q91639555 | Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults |
| Q35232470 | Plasma levels of procalcitonin and eight additional inflammatory molecules in febrile neutropenic patients |
| Q41678972 | Polymorphism rs2239185 in vitamin D receptor gene is associated with severe community-acquired pneumonia of children in Chinese Han population: a case-control study |
| Q33753353 | Predicting treatment failure in severe sepsis and septic shock: looking for the Holy Grail |
| Q35561237 | Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study |
| Q43786668 | Prevalence and predictive value of ionized hypocalcemia among critically ill patients |
| Q33974292 | Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine |
| Q40262183 | Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies |
| Q34999555 | Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. |
| Q34014835 | Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study |
| Q55966607 | Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia |
| Q35783372 | Procalcitonin Identifies Cell Injury, Not Bacterial Infection, in Acute Liver Failure |
| Q79680732 | Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children |
| Q83761995 | Procalcitonin and C-reactive protein in pericardial fluid for postmortem diagnosis of sepsis |
| Q33820468 | Procalcitonin and C-reactive protein in urinary tract infection diagnosis |
| Q64114449 | Procalcitonin and Proinflammatory Cytokines in Early Diagnosis of Bacterial Infections after Bronchoscopy |
| Q62169067 | Procalcitonin and pneumonia: Is it a useful marker? |
| Q47875461 | Procalcitonin and ventilator-associated pneumonia: yet another breath of fresh air. |
| Q38107483 | Procalcitonin as a biomarker of infectious diseases |
| Q45310337 | Procalcitonin as a diagnostic and prognostic biomarker of sepsis in critically ill children* |
| Q34325775 | Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis |
| Q90509471 | Procalcitonin as a prognostic marker of patients with acute ischemic stroke |
| Q35120524 | Procalcitonin as an adjunctive biomarker in sepsis |
| Q40377840 | Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia |
| Q31112286 | Procalcitonin as a tool for the assessment of successful therapy of severe sepsis : An analysis using clinical routine data |
| Q36152827 | Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. |
| Q37747406 | Procalcitonin for guidance of antibiotic therapy |
| Q35584452 | Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac surgery |
| Q40114391 | Procalcitonin in patients with influenza A (H1N1) infection and acute respiratory failure |
| Q91708556 | Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy |
| Q47812804 | Procalcitonin in severe acute respiratory syndrome (SARS). |
| Q40074249 | Procalcitonin is a Poor Predictor of Non-Infectious Fever in the Neurocritical Care Unit |
| Q40484571 | Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study |
| Q58763790 | Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational study |
| Q43777092 | Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia |
| Q57554486 | Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia |
| Q37210066 | Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome |
| Q40745926 | Procalcitonin level for prediction of postoperative infection in cardiac surgery |
| Q43614559 | Procalcitonin levels as an early marker in patients with multiple trauma under intensive care |
| Q34773984 | Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections |
| Q24811639 | Procalcitonin testing has the potential to reduce unnecessary antibiotic use in patients with suspected lower respiratory tract infections |
| Q26775450 | Procalcitonin to guide antibiotic therapy in the ICU |
| Q34017829 | Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial |
| Q45766081 | Procalcitonin to guide length of antibiotic therapy in surgical intensive care patients |
| Q41692073 | Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient |
| Q44492146 | Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis |
| Q34999385 | Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. |
| Q40174999 | Procalcitonin-Guided Antibiotics after Surgery for Peritonitis: A Randomized Controlled Study. |
| Q26798459 | Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit |
| Q47625363 | Procalcitonin-guided antibiotic treatment in heart failure |
| Q36815203 | Procalcitonin: a diagnostic and prognostic biomarker of sepsis in burned patients |
| Q90475369 | Prognostic Value of Serum Procalcitonin level for the Diagnosis of Bacterial Infections in Critically-ill Patients |
| Q35566943 | Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients |
| Q62169002 | Prognostic value of procalcitonin in Legionella pneumonia |
| Q41893491 | Prognostic value of serum procalcitonin and C-reactive protein levels in critically ill patients who developed ventilator-associated pneumonia. |
| Q41847155 | Proinflammatory cytokines in peritonitis. |
| Q44394953 | Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial. |
| Q38550893 | Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting |
| Q61757039 | Prävention, Diagnose, Therapie und Nachsorge der Sepsis |
| Q38171058 | Rapid diagnosis of sepsis |
| Q47672621 | Rationale and design of the IMPACT EU-trial: improve management of heart failure with procalcitonin biomarkers in cardiology (BIC)-18. |
| Q85910170 | Relationship between procalcitonin serum levels and functional outcome in stroke patients |
| Q38757517 | Role of Procalcitonin in Differentiating between Infectious and Noninfectious Fevers among Patients with Lymphoma |
| Q37249625 | Role of biomarkers in sepsis care. |
| Q92505823 | SIRS Triggered by Acute Right Ventricular Function, Mimicked Septic Shock |
| Q61757063 | Sepsis |
| Q30827175 | Sepsis affects most routine and cell population data (CPD) obtained using the Sysmex XN-2000 blood cell analyzer: neutrophil-related CPD NE-SFL and NE-WY provide useful information for detecting sepsis |
| Q39386095 | Sepsis biomarkers in neutropaenic systemic inflammatory response syndrome patients on standard care wards |
| Q38183729 | Sepsis biomarkers: an omics perspective |
| Q37981026 | Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances |
| Q36588933 | Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics |
| Q41918509 | Sepsis: A Review of Advances in Management |
| Q38453261 | Sepsis: a roadmap for future research |
| Q55332876 | Sequential Measurements of Pentraxin 3 Serum Levels in Patients with Ventilator-Associated Pneumonia: A Nested Case-Control Study. |
| Q53841398 | Serum concentration of chromogranin A at admission: an early biomarker of severity in critically ill patients. |
| Q46861953 | Serum levels of osteopontin are increased in SIRS and sepsis. |
| Q33325779 | Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria |
| Q34612152 | Serum procalcitonin level and SOFA score at discharge from the intensive care unit predict post-intensive care unit mortality: a prospective study |
| Q36392472 | Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department |
| Q36560376 | Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients |
| Q36849016 | Serum procalcitonine levels as an early diagnostic indicator of sepsis |
| Q56762347 | Severity markers in severe leptospirosis: a cohort study |
| Q41108172 | Should procalcitonin be measured routinely in acute decompensated heart failure? |
| Q34991149 | Significance of serum procalcitonin in sepsis |
| Q36160723 | Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis |
| Q33723537 | Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection |
| Q27321609 | Spontaneous neutrophil migration patterns during sepsis after major burns |
| Q38095145 | Streamlining antibiotic therapy with procalcitonin protocols: consensus and controversies |
| Q89276299 | Systemic Estrone Production and Injury-Induced Sex Hormone Steroidogenesis after Severe Traumatic Brain Injury: A Prognostic Indicator of Traumatic Brain Injury-Related Mortality |
| Q39178934 | The Diagnostic Accuracy of Serum Procalcitonin for Bacteremia in Critically Ill Children |
| Q92236835 | The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis |
| Q35862741 | The accuracy of presepsin for the diagnosis of sepsis from SIRS: a systematic review and meta-analysis |
| Q30415731 | The behavior and diagnostic utility of procalcitonin and five other inflammatory molecules in critically ill patients with respiratory distress and suspected 2009 influenza a H1N1 infection |
| Q40474709 | The clinical value of biomarkers in respiratory complications in hematopoietic SCT. |
| Q48371582 | The effect of sepsis and its inflammatory response on mechanical clot characteristics: a prospective observational study |
| Q27022093 | The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells |
| Q48438639 | The role of procalcitonin and N-terminal pro-B-type natriuretic peptide in predicting outcome after cardiac surgery. |
| Q38767901 | The use and risks of antibiotics in critically ill patients |
| Q40218016 | The utility of serum procalcitonin in distinguishing systemic inflammatory response syndrome from infection after aneurysmal subarachnoid hemorrhage. |
| Q33320335 | Toward an operative diagnosis in sepsis: a latent class approach. |
| Q98778915 | Transcriptomic study of lipopolysaccharide-induced sepsis damage in a mouse heart model |
| Q36972345 | Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock |
| Q36075949 | Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection. |
| Q36392555 | Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infe |
| Q40335693 | Use of procalcitonin (PCT) to guide discontinuation of antibiotic use in an unspecified sepsis is an antimicrobial stewardship program (ASP). |
| Q34020982 | Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial |
| Q51898034 | Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. |
| Q24678563 | Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit |
| Q37207285 | Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine. |
| Q33629591 | Using Procalcitonin to Guide Antibiotic Therapy |
| Q40534344 | Utility of Plasma Osteopontin Levels in Management of Community-Acquired Pneumonia |
| Q35070651 | Utility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patients |
| Q40402027 | Value of Procalcitonin Measurement for Early Evidence of Severe Bacterial Infections in the Pediatric Intensive Care Unit |
| Q58929221 | Value of procalcitonin for diagnosis of early onset pneumonia in hypothermia-treated cardiac arrest patients |
| Q85671986 | Ventilator-associated pneumonia |
| Q37597987 | Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality? |
| Q81234627 | [Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy] |
| Q87610156 | [Diagnostic markers and assessment of efficacy of antibacterial therapy] |
| Q40482831 | [Procalcitonin as an early marker of sepsis]. |
| Q84325877 | [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients] |
| Q91901969 | [The diagnosis of sepsis] |
| Q24815302 | Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN731826 |
Search more.